Germline engineering of the chicken genome using CRISPR/Cas9 by in vivo transfection of PGCs

Anim Biotechnol. 2023 Nov;34(4):775-784. doi: 10.1080/10495398.2020.1789869. Epub 2020 Jul 24.

Abstract

Development of simple and readily adoptable methods to mediate germline engineering of the chicken genome will have many applications in research, agriculture and industrial biotechnology. We report germline targeting of the endogenous chicken Interferon Alpha and Beta Receptor Subunit 1 (IFNAR1) gene by in vivo transgenic expression of the high-fidelity Cas9 (Cas9-HF1) and guide RNAs (gRNAs) in chickens. First, we developed a Tol2 transposon vector carrying Cas9-HF1, IFNAR1-gRNAs (IF-gRNAs) and green fluorescent protein (GFP) transgenes (pTgRCG) and validated in chicken fibroblast DF1 cells. Next, the pTgRCG plasmid was directly injected into the dorsal aorta of embryonic day (ED) 2.5 chicken embryos targeting the circulating primordial germ cells (PGCs). The resulting chimera roosters generated a fully transgenic generation 1 (G1) hen with constitutive expression of Cas9-HF1 and IF-gRNAs (G1_Tol2-Cas9/IF-gRNA). We detected a spectrum of indels at gRNA-targeted loci in the G1_Tol2-Cas9/IF-gRNA hen and the indels were stably inherited by the G2 progeny. Breeding of the G1_Tol2-Cas9/IF-gRNA hen resulted in up to 10% transgene-free heterozygote IFNAR1 mutants, following null-segregation of the Tol2 insert. The method described here will provide new opportunities for genome editing in chicken and other avian species that lack PGC culture.

Keywords: CRISPR/Cas9; chicken; in vivo transfection; primordial germ cells (PGCs).

MeSH terms

  • Animals
  • Animals, Genetically Modified / genetics
  • CRISPR-Cas Systems* / genetics
  • Chick Embryo
  • Chickens* / genetics
  • Female
  • Gene Editing / methods
  • Germ Cells / metabolism
  • Male
  • Transfection